Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 2 | $124,748 |
| Sells | 35 | $31,006,966 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 19 Aug 2024 21:07 | IMNM | Immunome Inc | BIENAIME JEAN JACQUES | Director | 16 Aug 2024 | Purchase | 7,000 | 13.944 | 97,608 | D |
| 22 May 2024 16:49 | IMNM | Immunome Inc | BIENAIME JEAN JACQUES | Director | 21 May 2024 | Purchase | 2,000 | 13.5699 | 27,140 | D |
| 13 May 2024 15:57 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 10 May 2024 | Sale | 20,000 | 81.14 | 1,622,800 | D |
| 13 May 2024 15:57 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 09 May 2024 | Sale | 20,000 | 81.62 | 1,632,400 | D |
| 15 Apr 2024 16:21 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 12 Apr 2024 | Sale | 20,000 | 91.26 | 1,825,200 | D |
| 15 Apr 2024 16:21 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 11 Apr 2024 | Sale | 20,000 | 90.99 | 1,819,800 | D |
| 07 Mar 2024 17:35 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 06 Mar 2024 | Sale | 1,000 | 86.713 | 86,713 | D |
| 07 Mar 2024 17:35 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 05 Mar 2024 | Sale | 1,000 | 85.51 | 85,510 | D |
| 29 Feb 2024 17:05 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 27 Feb 2024 | Sale | 1,000 | 90.35 | 90,350 | D |
| 12 Feb 2024 17:20 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 08 Feb 2024 | Sale | 15,000 | 89.77 | 1,346,550 | D |
| 12 Feb 2024 17:20 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 09 Feb 2024 | Sale | 15,000 | 88.28 | 1,324,200 | D |
| 11 Jan 2024 14:40 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 10 Jan 2024 | Sale | 10,000 | 96.38 | 963,800 | D |
| 11 Jan 2024 14:40 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 09 Jan 2024 | Sale | 10,000 | 98.19 | 981,900 | D |
| 22 Dec 2023 17:14 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Director | 21 Dec 2023 | Sale | 10,000 | 93.99 | 939,900 | D |
| 09 Aug 2023 19:05 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 08 Aug 2023 | Sale | 6,000 | 88.29 | 529,740 | D |
| 09 Aug 2023 19:05 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 07 Aug 2023 | Sale | 4,000 | 88.1 | 352,400 | D |
| 15 May 2023 16:58 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 11 May 2023 | Sale | 5,561 | 95.22 | 529,518 | D |
| 15 May 2023 16:58 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 11 May 2023 | Sale | 24,439 | 94.55 | 2,310,707 | D |
| 11 May 2023 17:04 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 10 May 2023 | Sale | 8,547 | 95.34 | 814,871 | D |
| 11 May 2023 17:04 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 10 May 2023 | Sale | 21,453 | 94.65 | 2,030,526 | D |
| 11 May 2023 17:04 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 09 May 2023 | Sale | 1,410 | 95.9 | 135,219 | D |
| 11 May 2023 17:04 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 09 May 2023 | Sale | 14,964 | 95.49 | 1,428,912 | D |
| 11 May 2023 17:04 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 09 May 2023 | Sale | 13,626 | 94.22 | 1,283,842 | D |
| 12 Apr 2023 16:08 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 10 Apr 2023 | Sale | 10,000 | 99.56 | 995,600 | D |
| 10 Apr 2023 19:00 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 06 Apr 2023 | Sale | 10,000 | 96.13 | 961,300 | D |
| 14 Mar 2023 19:40 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 13 Mar 2023 | Sale | 8,000 | 90.45 | 723,600 | D |
| 14 Mar 2023 19:40 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 10 Mar 2023 | Sale | 15,000 | 92.28 | 1,384,200 | D |
| 14 Feb 2023 20:00 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 13 Feb 2023 | Sale | 6,000 | 109.15 | 654,900 | D |
| 14 Feb 2023 20:00 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 10 Feb 2023 | Sale | 15,000 | 110.11 | 1,651,650 | D |
| 18 Jan 2023 21:41 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 17 Jan 2023 | Sale | 10,000 | 111.55 | 1,115,500 | D |
| 18 Jan 2023 21:41 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 13 Jan 2023 | Sale | 10,000 | 112.25 | 1,122,500 | D |
| 15 Dec 2022 16:43 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 13 Dec 2022 | Sale | 1,000 | 106.89 | 106,890 | D |
| 06 Dec 2022 21:09 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 02 Dec 2022 | Sale | 69 | 104.055 | 7,180 | D |
| 06 Dec 2022 21:09 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 02 Dec 2022 | Sale | 100 | 104 | 10,400 | D |
| 06 Dec 2022 21:09 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 02 Dec 2022 | Sale | 260 | 103.98 | 27,035 | D |
| 06 Dec 2022 21:09 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 02 Dec 2022 | Sale | 600 | 103.971 | 62,383 | D |
| 06 Dec 2022 21:09 | BMRN | BIOMARIN PHARMACEUTICAL INC | BIENAIME JEAN JACQUES | Chief Executive Officer | 02 Dec 2022 | Sale | 471 | 103.97 | 48,970 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)